1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6E776B2AB6A2D52FA002585DF0046EA9C
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/E776B2AB6A2D52FA002585DF0046EA9C?OpenDocument
18
19OpenDocument
2035.170.64.36
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Clinical Operations Clinical Trial Management

Document Excerpt: Best Practices for Managing Clinical Trials During and Beyond the COVID-19 Pandemic

DB Image

Excerpt in Cart

ID: MD-739


Features:

5 Info Graphics

14 Data Graphics

90 Metrics

26 Narratives


Pages/Slides: 5


Published: 2020


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5639 "Best Practices for Managing Clinical Trials During and Beyond the COVID-19 Pandemic”.

Industries Profiled:
Medical Device; Biotech; Biopharmaceutical; Clinical Research; Pharmaceutical; Health Care; Computer Software; Telecommunications; Laboratories


Companies Profiled:
Alcon; Alnylam Pharmaceuticals; Aptus Clinical; Atara Biotherapeutics; Cipla; CSL Behring; Cytiva; Idorsia; Kyowa Kirin; MedinCell; Merck; Novartis; Ora; Inc.; Sanofi; United BioSource

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.